- South Korea
- /
- Biotech
- /
- KOSDAQ:A203690
Further Upside For Sphere Power Inc. (KOSDAQ:203690) Shares Could Introduce Price Risks After 44% Bounce
Sphere Power Inc. (KOSDAQ:203690) shareholders would be excited to see that the share price has had a great month, posting a 44% gain and recovering from prior weakness. The annual gain comes to 206% following the latest surge, making investors sit up and take notice.
In spite of the firm bounce in price, Sphere Power may still be sending very bullish signals at the moment with its price-to-sales (or "P/S") ratio of 4.2x, since almost half of all companies in the Biotechs industry in Korea have P/S ratios greater than 10.9x and even P/S higher than 36x are not unusual. Nonetheless, we'd need to dig a little deeper to determine if there is a rational basis for the highly reduced P/S.
See our latest analysis for Sphere Power
How Sphere Power Has Been Performing
With revenue growth that's exceedingly strong of late, Sphere Power has been doing very well. Perhaps the market is expecting future revenue performance to dwindle, which has kept the P/S suppressed. If you like the company, you'd be hoping this isn't the case so that you could potentially pick up some stock while it's out of favour.
Although there are no analyst estimates available for Sphere Power, take a look at this free data-rich visualisation to see how the company stacks up on earnings, revenue and cash flow.What Are Revenue Growth Metrics Telling Us About The Low P/S?
There's an inherent assumption that a company should far underperform the industry for P/S ratios like Sphere Power's to be considered reasonable.
Taking a look back first, we see that the company grew revenue by an impressive 36% last year. The latest three year period has also seen an excellent 178% overall rise in revenue, aided by its short-term performance. Accordingly, shareholders would have definitely welcomed those medium-term rates of revenue growth.
When compared to the industry's one-year growth forecast of 36%, the most recent medium-term revenue trajectory is noticeably more alluring
With this information, we find it odd that Sphere Power is trading at a P/S lower than the industry. It looks like most investors are not convinced the company can maintain its recent growth rates.
The Final Word
Shares in Sphere Power have risen appreciably however, its P/S is still subdued. It's argued the price-to-sales ratio is an inferior measure of value within certain industries, but it can be a powerful business sentiment indicator.
We're very surprised to see Sphere Power currently trading on a much lower than expected P/S since its recent three-year growth is higher than the wider industry forecast. When we see strong revenue with faster-than-industry growth, we assume there are some significant underlying risks to the company's ability to make money which is applying downwards pressure on the P/S ratio. It appears many are indeed anticipating revenue instability, because the persistence of these recent medium-term conditions would normally provide a boost to the share price.
Don't forget that there may be other risks. For instance, we've identified 3 warning signs for Sphere Power (1 is concerning) you should be aware of.
It's important to make sure you look for a great company, not just the first idea you come across. So if growing profitability aligns with your idea of a great company, take a peek at this free list of interesting companies with strong recent earnings growth (and a low P/E).
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About KOSDAQ:A203690
Ark Solutions
Engages in the research and development of products using protein in South Korea, Japan, Mexico, and internationally.
Mediocre balance sheet low.